Halogenated Nucleosides
8-Aza-7-bromo-7-deazaguanosine
Quick view. We supply 8-Aza-7-bromo-7-deazaguanosine as a halogenated nucleoside analog for modified nucleoside, antiviral/antimetabolite and oligonucleotide precursor research. CAS 96555-37-2. Catalog target purity: Specification on request.
Product profile
8-Aza-7-bromo-7-deazaguanosine is classified as nucleoside or protected nucleoside intermediate (Formula C10H12BrN5O5; molecular weight 362.14).
8-Aza-7-bromo-7-deazaguanosine can serve as a starting material, protected intermediate or analytical comparator in nucleoside and nucleotide route development.
For 8-Aza-7-bromo-7-deazaguanosine, confirm the current specification, storage conditions and downstream-method compatibility before routine use.
Names and search terms
Confirmed or normalized name variants
- 3-Bromo-6-imino-1-pentofuranosyl-2,6-dihydro-1H-pyrazolo[3,4-d]pyrimidin-4-ol
- Aids001495
- 6-amino-3-bromo-1-β-D-ribofuranosylpyrazolo
- pyrimidin-4(5H)-one
- 6-Amino-3-bromo-1-.beta.-D-ribofuranosylpyrazolo[3,4-D]pyrimidin-4(5H)-one
- 6-Amino-3-bromo-1,5-dihydro-1-(-D-ribofuranosyl)-4H-pyrazolo[3,4-d]pyrimidin-4-one
- 6-Amino-3-bromo-1,5-dihydro-1-(beta-D-ribofuranosyl)-4H-pyrazolo[3,4-d]pyrimidin-4-one
- 4H-Pyrazolo[3,4-D]pyrimidin-4-one, 6-amino-3-bromo-1,5-dihydro-1-.beta.-D-ribofuranosyl-
Useful catalog search terms
- CAS 96555-37-2
- Nucleoside or protected nucleoside intermediate
- Halogenated Nucleosides
Physicochemical data
| InChI | InChI=1S/C10H12BrN5O5/c11-6-3-7(13-10(12)14-8(3)20)16(15-6)9-5(19)4(18)2(1-17)21-9/h,4-5,9,15,17-19H,1H2,(H2,12,14,20)/t2-,4-,5-,9-/m1/s |
|---|---|
| InChIKey | BHLVSWZYTNOECK-UBBGWMJQSA-N |
| SMILES | C([C@@H]1[C@H]([C@H]([C@@H](O1)N2C3=NC(=NC(=O)C3=C(N2)Br)N)O)O)O |
| Density | 2.62±0.1 g/cm3(Predicted) |
| pKa | 6.45±0.20(Predicted) |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Additional application examples
- Typical work includes protection/deprotection studies, phosphorylation or phosphitylation route scouting and impurity identification.
- The material can support medicinal-chemistry analog preparation and process-development feasibility studies.
Related products
2'-5-CF3-dU
Halogenated Nucleosides · CAS: 70-00-8
BX-HN-00026-Cl-purine-2'-deoxyriboside
Halogenated Nucleosides · CAS: 4594-45-0
BX-HN-00038-Cl-2'-dA
Halogenated Nucleosides · CAS: 85562-55-6
BX-HN-00042'-Chloro-2'-deoxycytidine
Halogenated Nucleosides · CAS: 10212-19-8
BX-HN-00055-bromo-2'-deoxycytidine
Halogenated Nucleosides · CAS: 1022-79-3
BX-HN-00065-Iodouridine
Halogenated Nucleosides · CAS: 1024-99-3
Frequently asked questions
Can the package size for 8-Aza-7-bromo-7-deazaguanosine be customized?
Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.
What information should be included in a quote request?
Quote catalog number BX-HN-0149 and CAS 96555-37-2, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.
Product-family literature
The publications below provide peer-reviewed context for the Halogenated Nucleosides product family and its named chemistry.